Get the Stockscreener App
0.5626
4.48%
0.0241
After Hours:
.57
0.0074
+1.32%
Klotho Neurosciences Inc stock is traded at $0.5626, with a volume of 768.41K.
It is up +4.48% in the last 24 hours and up +11.36% over the past month.
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
See More
Previous Close:
$0.5385
Open:
$0.5319
24h Volume:
768.41K
Relative Volume:
0.38
Market Cap:
$34.53M
Revenue:
-
Net Income/Loss:
$-11.35M
P/E Ratio:
-1.2354
EPS:
-0.4554
Net Cash Flow:
$-5.51M
1W Performance:
-6.31%
1M Performance:
+11.36%
6M Performance:
+253.84%
1Y Performance:
+3.04%
1-Day Range:
$0.52
$0.5699
1-Week Range:
$0.51
$0.6117
52-Week Range:
$0.1135
$3.9099
Klotho Neurosciences Inc Stock (KLTO) Company Profile
Name
Klotho Neurosciences Inc
Sector
Industry
Phone
(833) 931-6330
Address
13576 WALNUT STREET, SUITE A, OMAHA
Compare KLTO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KLTO
Klotho Neurosciences Inc
|
0.5626 | 33.05M | 0 | -11.35M | -5.51M | -0.4554 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Klotho Neurosciences Inc Stock (KLTO) Latest News
Is Klotho Neurosciences Inc. stock supported by strong fundamentalsEarnings Risk Report & Free Community Supported Trade Ideas - newser.com
Building trade automation scripts for Klotho Neurosciences Inc. Equity Warrant2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Is Klotho Neurosciences Inc. Equity Warrant stock attractive after correctionPortfolio Value Summary & Accurate Trade Setup Notifications - newser.com
Is now a turning point for Klotho Neurosciences Inc.2025 Valuation Update & Safe Capital Growth Tips - newser.com
What technical models suggest about Klotho Neurosciences Inc. Equity Warrant’s comebackJuly 2025 Sector Moves & Stepwise Trade Execution Plans - newser.com
Will Klotho Neurosciences Inc. stock benefit from commodity pricesMarket Trend Report & Weekly Market Pulse Alerts - newser.com
What to expect from Klotho Neurosciences Inc. in the next 30 daysAnalyst Upgrade & Verified Swing Trading Watchlists - newser.com
Will a bounce in Klotho Neurosciences Inc. Equity Warrant offer an exitPortfolio Growth Summary & Weekly Top Gainers Trade List - newser.com
Is Klotho Neurosciences Inc. Equity Warrant showing signs of accumulationTrade Performance Summary & Daily Market Momentum Tracking - newser.com
Is Klotho Neurosciences Inc. stock a safe investment in uncertain marketsJuly 2025 Market Mood & Precise Entry and Exit Recommendations - newser.com
How institutional ownership impacts Klotho Neurosciences Inc. stockJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
Why Klotho Neurosciences Inc. is moving today2025 Investor Takeaways & Community Consensus Trade Signals - newser.com
How sentiment analysis helps forecast Klotho Neurosciences Inc. Equity Warrant2025 Technical Overview & Stepwise Trade Signal Implementation - newser.com
Published on: 2025-10-21 19:33:17 - newser.com
Why Klotho Neurosciences Inc. stock appeals to analystsVolume Spike & Expert Curated Trade Setups - newser.com
Published on: 2025-10-20 19:53:15 - newser.com
Analyzing recovery setups for Klotho Neurosciences Inc. Equity Warrant investorsAnalyst Downgrade & Stepwise Entry and Exit Trade Signals - newser.com
Klotho Neurosciences Inc. stock volume spike explained2025 Buyback Activity & Expert Verified Stock Movement Alerts - newser.com
Can technical indicators confirm Klotho Neurosciences Inc. Equity Warrant’s reversal2025 Year in Review & Free High Accuracy Swing Entry Alerts - newser.com
How strong is Klotho Neurosciences Inc. Equity Warrant stock balance sheetQuarterly Earnings Report & Risk Managed Investment Entry Signals - newser.com
What analysts say about Klotho Neurosciences Inc Equity Warrant stockSell Signals and Alerts & Turn Market Volatility into Wealth - earlytimes.in
Cash per share of Klotho Neurosciences, Inc. Warrant 2024-21.06.29 on Klotho Neuroscience – NASDAQ:KLTOW - TradingView
Will Klotho Neurosciences Inc. Equity Warrant stock sustain high P E ratios2025 Market Overview & Weekly Market Pulse Updates - newser.com
Aug Mood: Why Klotho Neurosciences Inc. stock appeals to dividend seekersNew Guidance & Daily Oversold Stock Bounce Ideas - nchmf.gov.vn
Visual trend scoring systems applied to Klotho Neurosciences Inc.Global Markets & Stepwise Trade Execution Plans - newser.com
What technical charts say about Klotho Neurosciences Inc. stockWatch List & Stepwise Swing Trade Plans - nchmf.gov.vn
sbobet ทางเข้า - nchmf.gov.vn
What catalysts could drive Klotho Neurosciences Inc. Equity Warrant stock higherQuarterly Market Summary & Safe Capital Investment Plans - nchmf.gov.vn
What momentum indicators show for Klotho Neurosciences Inc. stockTrade Risk Summary & Risk Controlled Stock Alerts - nchmf.gov.vn
Is Klotho Neurosciences Inc. Equity Warrant forming a reversal patternGlobal Markets & Daily Price Action Insights - newser.com
Klotho Neurosciences, Inc.Common Stock (NQ: KLTO - FinancialContent
Will Klotho Neurosciences Inc. Equity Warrant stock keep outperforming rivalsJuly 2025 Pullbacks & Low Risk Investment Opportunities - nchmf.gov.vn
Klotho Neurosciences Inc Stock (KLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):